Altered biliary prostaglandins and cholesterol gallstones: An in vivo study

Abstract

Recent investigations suggest that biliary prostaglandin metabolism is altered during cholesterol gallstone formation. Most of the available data, however, has been obtained from in vitro studies. The purpose of the present study was to define the effects of cholesterol gallstone formation on in vivo biliary prostaglandin metabolism. Male prairie dogs were fed either a control chow for 21 days or a 1.2% cholesterol-enriched chow for 14–21 days. Cholecystectomy was performed and gallbladder tissue and bile were collected for analysis of prostaglandin concentrations using radioimmunoassay techniques. Gallbladder bile was examined for the presence of crystals and stones. No control animals but all cholesterolfed animals developed either cholesterol crystals or gallstones ( P < 0.001). Concentrations of prostaglandin E 2, prostaglandin F 2 (PGF 2α), and the stable metabolic products of prostacyclin and thromboxane A 2, 6-keto-PGF 1α and thromboxane B 2 (TXB 2), respectively, were decreased 60–85% in the gallbladder tissue of animals with crystals and gallstones compared to controls. Additionally, gallstone containing animals and those with crystals demonstrated a significant increase in the gallbladder bile concentrations of PGF 2α, 6-keto-PGF 1α, and TXB 2. These findings lend support to previously reported in vitro studies suggesting that prostaglandin synthesis increases at an early stage of experimentally induced cholesterol gallstone formation.